Co-morbidities in persons infected with HIV: Increased burden with older age and negative effects on health-related quality of life

AIDS Patient Care and STDs

Volumn 27, Issue 1, 2013, Pages 5-16

  Rodriguez Penney, Alan T ^a   Iudicello, Jennifer E ^b   Riggs, Patricia K ^b   Doyle, Katie ^b   Ellis, Ronald J ^c   Letendre, Scott L ^d   Grant, Igor ^b   Woods, Steven Paul ^b  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; MISCELLANEOUS DRUGS AND AGENTS;

ADULT; AGING; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; CHARLSON COMORBIDITY INDEX; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASES; DISTRESS SYNDROME; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GROUPS BY AGE; HEART INFARCTION; HEMIPLEGIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIFESPAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PARAPLEGIA; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; POLYPHARMACY; PREVALENCE; QUALITY OF LIFE; SEXUAL ORIENTATION; SOLID TUMOR; VIRUS LOAD;

ADULT; AGE FACTORS; AGED; AGING; CALIFORNIA; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; VIRAL LOAD;

EID: 84872363435     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0329     Document Type: Article

References (76)

1. Center for Disease Control and Prevention. HIV Surveillance Report, 2010. Atlanta: U.S. Department of Health and Human Services, CDC 2011.
2. Hughes AK. HIV knowledge and attitudes among providers in aging: Results from a national survey. AIDS Patient Care STDs 2011;25:539-545.
3. Center for Disease Control and Prevention. HIV Surveillance Report, 2008. Atlanta: U.S. Department of Health and Human Services, CDC 2009.
4. Blanco JR, Caro AM, Pérez-Cachafeiro S, et al. HIV infection and aging. AIDS Rev 2010;12:218-230.
5. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: The Hawaii Aging with HIV-1 Cohort. Neurology 2004;63:822-827.
6. Phillips AN, Lee CA, Elford J, et al. More rapid progression to AIDS in older HIV-infected people: The role of CD4+ Tcell counts. J Acquir Immune Defic Syndr 1991;4:970-975.
7. Egger M, Chene G, Phillips AN, et al. Prognosis of HIV-1 infected patient starting highly active antiretroviral therapy: A collaborative analysis of prospective studies. Lancet 2002;360;119-129.
8. Bamford, LM, Ehrenkranz PD, Eberhart MG, et al. Factors associated with delayed entry into primary HIV medical care after HIV diagnosis. AIDS 2010; 24:928-930.
9. Gardner ID. The effect of aging on susceptibility to infection. Rev Infect Dis 1980;2:801-810.
10. Morgan EE, Iudicello JE, Weber E, et al. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr 2012;61:341-348.
11. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012; 60:S1-S18.
12. Hernandez MD, Sherman KE. HIV/hepatitis C coinfection natural history and disease progression. Curr Opin HIV AIDS 2011;6:478-482.
13. McCutchan JA, Marquie-Beck JA, Fitzsimmons CA, et al. Role of obesity, metabolic variables, and diabetes in HIVassociated neurocognitive disorders. Neurology 2012;14: 485-492.
14. Hinkin CH, Castellon SA, Levine AJ, et al. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addictive Dis 2008;27:11-17.
15. Kilbourne AM, Justice AC, Rabeneck L, et al. General medical and psychiatric co-morbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol 2001;54: S22-28.
16. Alencastro PR, Fuchs SC, Wolff FH, et al. Independent predictors of metabolic syndrome in HIV-infected patients. AIDS Patient Care STDs 2011;25:627-634.
17. Backus LI, Boothroyd D, Philips B, et al. Assessment of the quality of diabetes care for HIV-infected patients in a national health care system. AIDS Patient Care STDs 2011;25: 203-206.
18. Vance D, Larsen KI, Eagerton G, et al. Co-morbidities and cognitive functioning: Implications for nursing research and practice. J Neurosci Nurs 2011;43:215-224.
19. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009; 338:288-292.
20. Guaraldi G, Orlando G, Zona S, et al. Premature age-related co-morbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011;53:1120-1126.
21. Oursler KK, Goulet JL, Crystal S, et al. Association of age and co-morbidity with physical function in HIV-infected and uninfected patients: Results from the Veterans Aging Cohort Study. AIDS Patient Care STDs 2011;25:13-20.
22. Goulet JL, Fultz SL, Rimland D, et al. Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007;45:1593-1601.
23. Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: The Swiss HIV cohort study. Clin Infect Dis 2011;53:1130-1139.
24. Weiss JJ, Osorio G, Ryan E, et al. Prevalence and patient awareness of medical co-morbidities in an urban AIDS clinic. AIDS Patient Care STDs 2010;24:39-48.
25. Peters L, Neuhaus J, Mocroft A, et al. Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis coinfected persons interrupting antiretroviral therapy in the SMART study. Antivir Ther 2011;16:667-675.
26. Oursler KK, Goulet JL, Leaf DA, et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 2006;20:782-791.
27. Woods SP, Dawson MS, Weber E, et al. The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol 2010;32:398-407.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, D.C.: American Psychiatric Association; 1994.
29. World Health Organization. Composite International Diagnostic Interview (CIDI, version 2.1). Geneva, Switzerland: WHO; 1998.
30. Wechsler D. Wechsler Test of Adult Reading. San Antonio, TX: Psychological Corporation, 2001.
31. Hall SF. A user's guide to selecting a co-morbidity index for clinical research. J Clin Epidemiol 2005;59:849-855.
32. Skiest DJ, Rubinstien E, Carley N, et al. The importance of co-morbidity in HIV-infected patients over 55: A retrospective case-control study. Am J Med 1996;101:605-611.
33. Lohse N, Gerstoft J, Kronborg G, et al. Co-morbidity acquired before HIV diagnosis and mortality in persons infected and uninfected with HIV: A Danish population-based cohort study. J Acquir Immune Defic Syndr 2011;57:334-339.
34. Tumbarello M, Rabagliati R, de Gaetano Donati K, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active anti retroviral yherapy. BMC Infect Dis 2004;4:46.
35. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40: 373-383.
36. Zavascki AP, Fuchs SC. The need for reappraisal of AIDS score weight of Charlson co-morbidity index. J Clin Epidemiol 2007;60:867-868.
37. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
38. Heaton RK, Clifford DB, Franklin DR, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 2010;75:2087-2096.
39. Heaton RK, Franklin DR, Ellis EJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. J Neurovirol 2011;17:3-16.
40. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69:1789-1799.
41. Woods SP, Morgan EE, Dawson M, et al. Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1. J Clin Exp Neuropsychol 2006;28:1030-1042.
42. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 2004;26:759-778.
43. Lawton MP, Brody EM. Assessment of older people: Selfmaintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
44. Heaton RK, Marcotte TD, Rivera-Mindt M, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004;10: 317-331.
45. Woods SP, Iudicello JE, Moran LM, et al. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology 2008;22: 110-117.
46. McNair DM, Lorr M, Droppleman LF. Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1981.
47. Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study. Qual Life Res 2000;9:55-63.
48. Lamping DL. Methods for measuring outcomes to evaluate interventions to improve health-related quality of life in HIV infection. Psychol Health 1994;9:31-49.
49. Jia H, Uphold CR, Wu S, et al. Health-related quality of life among men with HIV infection: Effects of social support, coping, and depression. AIDS Patient Care STDs 2004;18: 594-603.
50. Nokes KM. Symptom disclosure by older HIV-infected persons. J Assoc Nurses AIDS Care 2011;22:186-192.
51. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005;352: 48-62.
52. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689.
53. Monroe AK, Chander G, Moore RD. Control of medical comorbidities in individuals with HIV. J Acquir Immune Defic Syndr 2011;58:458-452.
54. Grabar S, Kousignian I, Sobel A, et al. Immunological and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 2004;18:2029-2038.
55. Reekie J. Kosa C, Engsig F, et al. Relationship between current level of immunodeficiency and nonacquired immunodeficiency syndromes-defining malignancies. Cancer 2010; 116:5306-5315.
56. Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
57. Iudicello JE, Woods SP, Deutsch R, Grant I, The HNRP Group. Combined effects of aging and HIV infection on semantic verbal fluency: A view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol 2012;34:476-488.
58. Barclay TR, Hinkin CH, Castellon SA, et al. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol 2007;26:40-49.
59. Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: The impact of age and cognition. J Clin Exp Neuropsychol 2011;33:200-209.
60. Schuster RM, Gonzalez R. Substance abuse, hepatitis C, and aging in HIV: Common cofactors that contribute to neurobehavioral disturbances. Neurobehav HIV Med 2012;4: 15-34.
61. Grunfeld C, Delaney JA, Wanke C, et al. Preclinical atherosclerosis due to HIV infection: Carotid intima-medial thickness measurements from the FRAM study. AIDS 2009;23: 1841-1849.
62. Kamat R, Woods SP, Marcotte TD, et al. Implications of apathy for everyday functioning outcomes in persons living with HIV infection. Arch Clin Neuropsychol 2012;27: 520-531.
63. Tate D, Paul RH, Flanigan TP, et al. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDS 2003;17:115-120.
64. Zisook S, Peterkin J, Goggin KJ, et al. Treatment of major depression in HIV-seropositive men. J Clin Psychiatry 1998;59:217-224.
65. Neidig JL, Smith BA, Brashers DE. Aerobic exercise training for depressive symptom management in adults living with HIV infection. J Assoc Nurses AIDS Care 2003;14:30-40.
66. Doyle K, Weber E, Atkinson JH, Grant I, Woods SP, The HNRP Group. Aging, prospective memory, and health-related quality of life in HIV infection. AIDS Behav 2012;16:2309-2318.
67. Ellis RJ, Deutsch R, Heaton, RK, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol 1997;54:416-424.
68. Tozzi V, Balestra P, Serraino D, et al. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses 2005;21:706-713.
69. Cederfjä ll C, Languis-Eklö f A, Lidman K, Wredling R. Gender difference in perceived health-related quality of life among patients with HIV infection. AIDS Patient Care STDS 2001;15:31-39.
70. O'Keefe EA, Wood R. The impact of human immunodeficiency virus (HIV) on quality of life in a multiracial South African population. Qual Life Res 1996;5:275-280.
71. Holzemer WL, Gygax Spicer J, Skodol Wilson H, Kemppainen JK, Coleman C. Validation of the quality of life scale: Living with HIV. J Adv Nurs 1998;28:622-630.
72. Health and Human Services Agency. HIV/AIDS Epidemiology Report, 2012 San Diego: County of San Diego Health and Human Services Agency (HHSA) 2012.
73. Campsmith ML, Nakashima AK, Davidson AJ. Self-reported health-related quality of life in persons with HIV infection: Results from a multi-site interview project. Health Qual Life Outcomes 2003;1:12.
74. Sørensen K, Van den Broucke S, Fullam J et al. Health literacy and public health: A systematic review and integration of definitions and models. BMC Public Health 2012;25: 12-80.
75. Friis-Møller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
76. Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010;55:262-270.